|
TERF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.542600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.427600E-01 |
| Normal-vs-Stage2 |
1.778490E-02 |
| Normal-vs-Stage3 |
7.61240000000107E-05 |
| Normal-vs-Stage4 |
2.790100E-04 |
| Stage1-vs-Stage2 |
1.775510E-02 |
| Stage1-vs-Stage3 |
1.67895999999557E-05 |
| Stage1-vs-Stage4 |
1.217450E-04 |
| Stage2-vs-Stage3 |
4.203200E-01 |
| Stage2-vs-Stage4 |
4.433600E-01 |
| Stage3-vs-Stage4 |
9.921600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.239600E-03 |
| Normal-vs-AfricanAmerican |
1.240000E-01 |
| Normal-vs-Asian |
8.240400E-01 |
| Caucasian-vs-AfricanAmerican |
9.611400E-01 |
| Caucasian-vs-Asian |
2.695000E-01 |
| AfricanAmerican-vs-Asian |
3.829600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.856500E-03 |
| Normal-vs-Female |
1.585440E-01 |
| Male-vs-Female |
7.854500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.922300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.679220E-01 |
| Normal-vs-Age(61-80Yrs) |
2.358900E-03 |
| Normal-vs-Age(81-100Yrs) |
5.901500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.070800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.983200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.311000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.754400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.040170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.109200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.861800E-02 |
| Normal-vs-Grade 2 |
4.254000E-01 |
| Normal-vs-Grade 3 |
4.420500E-03 |
| Normal-vs-Grade 4 |
4.23449999997771E-06 |
| Grade 1-vs-Grade 2 |
3.951900E-02 |
| Grade 1-vs-Grade 3 |
5.922100E-03 |
| Grade 1-vs-Grade 4 |
1.831880E-04 |
| Grade 2-vs-Grade 3 |
1.099850E-02 |
| Grade 2-vs-Grade 4 |
3.03420000002941E-06 |
| Grade 3-vs-Grade 4 |
1.207770E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.283200E-01 |
| Normal-vs-ccB subtype |
6.20350000000158E-05 |
| ccA subtype-vs-ccB subtype |
1.07249999992121E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.759000E-03 |
| Normal-vs-N1 |
7.039200E-03 |
| N0-vs-N1 |
2.167200E-01 |
|
|
